ALVO.IC is trading 4.6% up today at $482.00, extending Monday’s gains as the move appears driven by renewed biotech interest and general market risk appetite.
- The stock continues its upward trend after rising from $453.00 to $461.00 on Monday, despite a lack of fresh earnings or FDA decisions.
- No major corporate events have been announced since mid-June’s $125 million public offering and concurrent private placement.
- The price action suggests a momentum-driven move rather than a response to specific company-specific catalysts.